Table 1.
Baseline sociodemographic and clinical characteristics of patients living with HIV/AIDS in Northern Ethiopia, 2009–2017.
| Variables | Exposure to IPT | ||
|---|---|---|---|
| No (ART alone) | Yes (IPT and ART) | ||
| Sex | Male | 500 (69.2%) | 223 (30.8%) |
| Female | 742 (65.1%) | 398 (34.9%) | |
| Age (in years) | <15 | 75 (63.0%) | 44 (37.0%) |
| 15–29 | 235 (70.4%) | 99 (29.6%) | |
| 30–44 | 698 (65.9%) | 361 (34.1%) | |
| 45–59 | 210 (66.5%) | 106 (33.5%) | |
| ≥60 | 24 (68.6%) | 11 (31.4%) | |
| Residence | Rural | 412 (67.0%) | 203 (33.0%) |
| Urban | 930 (66.5%) | 418 (33.5%) | |
| Functional status | Working | 827 (66.3%) | 420 (33.7%) |
| Ambulatory | 318 (66.4%) | 161 (33.6%) | |
| Bedridden | 97 (70.8%) | 40 (29.2%) | |
| World Health Organization clinical staging | Stage I | 178 (63.1%) | 104 (36.9%) |
| Stage II | 251 (61.1%) | 160 (38.9%) | |
| Stage III | 649 (68.7%) | 296 (31.3%) | |
| Stage IV | 164 (72.9%) | 61 (27.1%) | |
AIDS: acquired immune deficiency syndrome; ART: antiretroviral therapy; HIV: human immunodeficiency virus; IPT: isoniazid preventive therapy.